ArticleACS medicinal chemistry letters2025

Novel Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitors for the Treatment of Parkinson's Disease.

Zhendong Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.